Open AccessA scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer
Author(s) -
Yash B. Shah,
Amy L. Shaver,
William Kevin Kelly,
Grace LuYao
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0273826
Subject(s) - enzalutamide , prostate cancer , medicine , abiraterone acetate , protocol (science) , clinical trial , population , abiraterone , adverse effect , oncology , intensive care medicine , cancer , androgen deprivation therapy , alternative medicine , pharmacology , androgen receptor , pathology , environmental health